相关实验视频
Updated: Jul 2, 2025

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
与Legionella相关的炎症模式在HIV和肺炎联合感染中
Breanne M Head1, Adriana Trajtman1, Ruochen Mao1
1Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
艾滋病毒患者的军团菌感染与特定的炎症标志物有关,包括eotaxin,IP-10和MCP-1. 这种免疫特征与重症监护室入院人数的增加和临床结果的恶化有关.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 艾滋病毒/艾滋病研究研究
背景情况:
- 军团菌感染不成比例地影响艾滋病毒感染的个体,往往导致严重的疾病.
- 对于免疫受损人群中宿主免疫反应对军团菌的理解有限.
研究的目的:
- 为了研究患有军菌肺炎的艾滋病毒患者的炎症概况.
- 为了将这些概况与临床结果和重症监护室 (ICU) 入院率相关联.
主要方法:
- 对来自哥伦比亚肺炎艾滋病毒患者的血样本的分析.
- 使用实时PCR检测军团菌,并通过基于珠子的技术测量系统性细胞因子.
- 莱吉欧内拉阳性和阴性患者组之间的结局的比较.
主要成果:
- 军团菌感染与高血水平的eotaxin,IP-10和MCP-1有关.
- 呈现这种炎症特征的患者在ICU入院的可能性更高.
- 这些细胞因子表明单细胞/巨细胞的激活和分化.
结论:
- 单细胞/巨细胞激活的全身标记与艾滋病毒患者的莱吉欧内拉感染有关.
- 鉴定出的细胞因子 (eotaxin,MCP-1,IP-10) 与较差的临床结果有关.
- 需要进一步的研究来阐明这种特征在莱吉欧内拉肺炎发病过程中的作用.
更多相关视频
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
12:30Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
Published on: November 22, 2013
相关概念视频
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: